Erythrocyte protoporphyrins in hepatitis C viral infection

Clinical Biochemistry

Volumn 33, Issue 5, 2000, Pages 387-391

  Vogeser, Michael ^a   Jacob, Karl ^a   Zachoval, Reinhart ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Hepatitis C; Liver; Protoporphyrin; Zinc protoporphyrin

Indexed keywords

BILIRUBIN; ERYTHROCYTE PROTOPORPHYRIN; HEME; PROTOPORPHYRIN ZINC;

ADULT; AGED; ARTICLE; BILIARY EXCRETION; BILIRUBIN BLOOD LEVEL; CELL LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEPATITIS C; HUMAN; LIVER METABOLISM; MALE; PORPHYRIN METABOLISM; PRIORITY JOURNAL;

EID: 0033772444     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00149-1     Document Type: Article

References (37)

1. Urinary porphyrins in liver disease
2. Urinary porphyrin excretion in hepatitis C infection
3. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association
4. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
5. Liver metabolism of porphyrins and heme
6. Zinc protoporphyrin: A product of iron-deficient erythropoiesis
7. The porphyrias
8. Erythropoietic protoporphyria
9. The liver in protoporphyria
10. Hepatic complications of erythropoietic protoporphyria
11. The effect of porphyrins on cellular redox system: A study on the dark effect of porphyrins on phagocytes
12. Exogenous protoporphyrin inhibits Hep G2 cell proliferation, increases the intracellular hydrogen peroxide concentration and causes ultrastructural alterations
13. Protoporphyrin IX and oxidative stress
14. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria
15. Hepatobiliary implications and complications in protoporphyria: A 20-year study
16. Erythropoietic protoporphyria and hepatic complications
17. Ion-pair high-performance liquid chromatographic determination of porphyrins from red blood cells
18. Application of ion pair high performance liquid chromatography to the analysis of porphyrins in clinical samples
19. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo
20. Hepatic clearance and biliary secretion of protoporphyrin in isolated, in situ-perfused rat liver
21. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport
22. Protoporphyrin-IX induced impairment of biliary lipid secretion in the rat
23. Long-term follow-up after liver transplantation for erythropoietic protoporphyria
24. 5-Aminolevulinic acid-based photodynamic therapy
25. Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment
26. Protoporphyrin, cirrhosis and hepatoma in the livers of mice given griseofulvin
27. Porphyrias, porphyrins and hepatocellular cancer
28. Heme enzyme patterns in rat liver nodules and tumors
29. Abnormality of heme synthesis as the initial lesion in carcinogenesis
30. Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence
31. Porphyrins, porphyrias, cancer and photodynamic therapy - A model for carcinogenesis
32. The porphyrias and hepatocellular carcinoma
33. Hepatitis C and hepatocellular carcinoma
34. The heme oxygenase-carbon monoxide system: A regulator of hepatobiliary function
35. Chenodeoxycholic acid therapy in erythrohepatic protoporphyria
36. Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: Results of a long-term follow-up trial
37. Long-term treatment of chronic hepatitis C with ursodesoxycholic acid: Influence of HCV genotypes and severity of liver disease